InsiderClue
Stocks · Health care · Services-Medical Laboratories

GRAIL, Inc.

GRAL Clue Score54
United States Fiscal year ends December CIK 0001699031
$140.58 +6.01% Close, 9 Oct 2026
Alert on the numbers Alert on insider trades
Price $140.58 +97.64% Close, 9 Oct 2026

Closing prices at the end of each trading day, from 25 Jun 2024. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
RevenueOperating incomeNet income
Fiscal year 2023Revenue55.6Operating income−5,442.9Net income−5,399.1EPS, diluted−173.89Fiscal year 2023Revenue93.1 +67.6%Operating income−1,515.4Net income−1,465.7EPS, diluted−47.21Fiscal year 2024Revenue125.6 +34.9%Operating income−2,189.2Net income−2,027.0EPS, diluted−63.54Fiscal year 2025Revenue147.2 +17.2%Operating income−562.2Net income−408.4EPS, diluted−11.11
FY2023FY2023FY2024FY2025
Revenue 55.6 93.1 125.6 147.2
Growth +67.6% +34.9% +17.2%
Operating income −5,442.9 −1,515.4 −2,189.2 −562.2
Net income −5,399.1 −1,465.7 −2,027.0 −408.4
Growth
EPS, diluted −173.89 −47.21 −63.54 −11.11
Growth

Margins

How much of each dollar of revenue it keeps. Point at a year for the detail.
Operating marginNet margin
Fiscal year 2023Operating margin−9,798.2%Net margin−9,719.3%Free cash flow margin−1,051.6%Fiscal year 2023Operating margin−1,627.6%Net margin−1,574.2%Free cash flow margin−653.8%Fiscal year 2024Operating margin−1,743.0%Net margin−1,613.9%Free cash flow margin−463.7%Fiscal year 2025Operating margin−382.0%Net margin−277.5%Free cash flow margin−203.8%
FY2023FY2023FY2024FY2025
Operating margin −9,798.2% −1,627.6% −1,743.0% −382.0%
Net margin −9,719.3% −1,574.2% −1,613.9% −277.5%
Free cash flow margin −1,051.6% −653.8% −463.7% −203.8%

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flowCapital expenditureFree cash flow
Fiscal year 2023Operating cash flow−561.3Capital expenditure−22.9Free cash flow−584.2Fiscal year 2023Operating cash flow−595.8Capital expenditure−12.9Free cash flow−608.7Fiscal year 2024Operating cash flow−577.2Capital expenditure−5.2Free cash flow−582.4Fiscal year 2025Operating cash flow−299.0Capital expenditure−0.9Free cash flow−299.9
FY2023FY2023FY2024FY2025
Operating cash flow −561.3 −595.8 −577.2 −299.0
Capital expenditure −22.9 −12.9 −5.2 −0.9
Free cash flow −584.2 −608.7 −582.4 −299.9
Growth

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
Cash
Fiscal year 2023Cash241.6Fiscal year 2023Cash97.3Fiscal year 2024Cash214.2Shareholders’ equity2,503.4Fiscal year 2025Cash249.7Shareholders’ equity2,577.9
FY2023FY2023FY2024FY2025
Cash 241.6 97.3 214.2 249.7
Shareholders’ equity n/a n/a 2,503.4 2,577.9

In millions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2025 · 10-K

Cash flow

In millions of USD, except per-share figures; shares in millions. Fiscal years ending December, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2023 1 Jan 2023 FY2023 31 Dec 2023 FY2024 31 Dec 2024 FY2025 31 Dec 2025
Operations
−561.3 −595.8 −577.2 −299.0
Growth
Investment
−22.9 −12.9 −5.2 −0.9
calc −584.2 −608.7 −582.4 −299.9
Growth
calc −18.81 −19.60 −18.26 −8.16
−22.9 −12.9 −551.0 −85.0
Financing
604.8 463.8 1,244.3 423.3

Lines marked calc are worked out here from filed figures; point at one for how. Capital expenditure, dividends and buybacks are shown as money out, so negative.